Formycon Announces Health Canada Approval Of Ranibizumab Biosimilar

Product Is Already Launched Across US, Europe And MENA

 
• By Chloe Kent
  
Businessman giving thumbs up in front of Canadian flag
Commercial launch is expected during Q1 of 2024 • Source: Shutterstock

More from Biosimilars

More from Products